Acorah Software Products - Accounts Production 16.5.460 false true 31 December 2023 1 January 2023 false 1 January 2024 31 December 2024 31 December 2024 10559287 Mr Skander Handous iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10559287 2023-12-31 10559287 2024-12-31 10559287 2024-01-01 2024-12-31 10559287 frs-core:CurrentFinancialInstruments 2024-12-31 10559287 frs-core:ComputerEquipment 2024-12-31 10559287 frs-core:ComputerEquipment 2024-01-01 2024-12-31 10559287 frs-core:ComputerEquipment 2023-12-31 10559287 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2024-01-01 2024-12-31 10559287 frs-core:SharePremium 2024-12-31 10559287 frs-core:ShareCapital 2024-12-31 10559287 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 10559287 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 10559287 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 10559287 frs-bus:SmallEntities 2024-01-01 2024-12-31 10559287 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 10559287 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 10559287 frs-bus:Director1 2024-01-01 2024-12-31 10559287 frs-countries:EnglandWales 2024-01-01 2024-12-31 10559287 2022-12-31 10559287 2023-12-31 10559287 2023-01-01 2023-12-31 10559287 frs-core:CurrentFinancialInstruments 2023-12-31 10559287 frs-core:SharePremium 2023-12-31 10559287 frs-core:ShareCapital 2023-12-31 10559287 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31
Registered number: 10559287
Innohealth Limited
Unaudited Financial Statements
For The Year Ended 31 December 2024
Innohealth Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2—3

Page 1
Innohealth Limited
Balance Sheet
As At 31 December 2024
Balance Sheet
Registered number: 10559287

| 2024 | 2023
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
CURRENT ASSETS
Debtors | 5 | 294,677 |  | 314,855 |
Cash at bank and in hand |  | 17,088 |  | 47,998 |
|  | 311,765 |  | 362,853 |
Creditors: Amounts Falling Due Within One Year | 6 | (139,127 ) |  | (138,881 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 172,638 |  | 223,972
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 172,638 |  | 223,972
NET ASSETS |  |  | 172,638 |  | 223,972
CAPITAL AND RESERVES
Called up share capital | 7 |  | 17,173 |  | 17,173
Share premium account |  |  | 281,179 |  | 281,179
Profit and Loss Account |  |  | (125,714 ) |  | (74,380 )
SHAREHOLDERS' FUNDS |  |  | 172,638 |  | 223,972

For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr Skander Handous Director
6 October 2025

The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Innohealth Limited
Notes to the Financial Statements
For The Year Ended 31 December 2024
Notes to the Financial Statements
1. General Information
Innohealth Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10559287 . The registered office is Henge Barn, Pury Hill Business Park, Alderton Road, Towcester, Northamptonshire, NN12 7LS.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Intellectual Property
Intellectual property assets are patents It was amortised to the profit and loss account over its estimated economic life of 10 years and is now written off.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Computer Equipment | Over 3 years

2.5. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
4. Tangible Assets

| Computer Equipment
--- | ---
| £
Cost
As at 1 January 2024 | 1,980
As at 31 December 2024 | 1,980
Depreciation
As at 1 January 2024 | 1,980
As at 31 December 2024 | 1,980
Net Book Value
As at 31 December 2024 | -
As at 1 January 2024 | -

Page 2
Page 3
Innohealth Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
5. Debtors

| 2024 |  | 2023
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 271,315 |  | 297,797
Other debtors | 23,362 |  | 17,058
| 294,677 |  | 314,855

6. Creditors: Amounts Falling Due Within One Year

| 2024 |  | 2023
--- | --- | --- | ---
| £ |  | £
Amounts owed to group undertakings | 110,593 |  | 107,438
Other creditors | 28,534 |  | 31,008
Taxation and social security | - |  | 435
| 139,127 |  | 138,881

7. Share Capital

| 2024 |  | 2023
--- | --- | --- | ---
| £ |  | £
Called Up Share Capital not Paid | 17,058 |  | 17,058
Called Up Share Capital has been paid up | 115 |  | 115
Amount of Allotted, Called Up Share Capital | 17,173 |  | 17,173

Page 3